Prescription drug · ANDA
Riluzole NDC 42291-775
Riluzole 50 mg/1 · Tablet, Film coated · Oral · AvKARE
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42291-775-60 | 42291077560 | 60 TABLET, FILM COATED in 1 BOTTLE (42291-775-60)Marketed from Oct 7, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Riluzole
- Generic name (nonproprietary)
- riluzole
- Active ingredients
- Riluzole — 50 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- AvKARENDC labeler code 42291
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 206045
- Marketing start
- Listing expires
- Other FDA classes
- Benzothiazoles (Chemical structure)
- Identifiers
- Product ID 42291-775_4c362542-247a-50f1-e063-6394a90a5065SPL ID 4c362542-247a-50f1-e063-6394a90a5065SPL set ID b117b981-476c-f9b8-e053-2995a90aee5fRxCUI 199206UNII 7LJ087RS6FUPC 0342291775602
- Pharmacologic class
- Benzothiazole
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442291077560followed by a unit qualifier and the quantityPackage 42291-0775-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Riluzole tablets is indicated for the treatment of amyotrophic lateral sclerosis (ALS). Riluzole tablets is indicated for the treatment of amyotrophic lateral sclerosis (ALS) ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 42291-775
- What is NDC 42291-775?
- 42291-775 is the product NDC for Riluzole, Riluzole 50 mg/1 tablet, film coated, listed with the FDA by AvKARE. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Riluzole.
- What is the active ingredient?
- Riluzole.
- Who is the labeler?
- AvKARE, NDC labeler code 42291. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Riluzole?
- 4 other product NDCs are listed under this name. See all Riluzole NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Riluzole products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Riluzole | Riluzole 50 mg/1 | Tablet, Film coatedOral | Florida Pharmaceutical Products, LLC | 69076-200 | 69076-0200-60 |
| Riluzole | Riluzole 50 mg/1 | TabletOral | Ascend Laboratories, LLC | 67877-286 | 67877-0286-0567877-0286-1067877-0286-14+2 more |
| Riluzole | Riluzole 50 mg/1 | Tablet, Film coatedOral | Sun Pharmaceutical Industries, Inc. | 62756-538 | 62756-0538-1862756-0538-8362756-0538-86+1 more |
| riluzole | Riluzole 50 mg/1 | Tablet, Film coatedOral | Glenmark Pharmaceuticals Inc., USA | 68462-381 | 68462-0381-1068462-0381-60 |
Other NDCs under ANDA 206045
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Riluzole | Riluzole 50 mg/1 | Tablet, Film coatedOral | Florida Pharmaceutical Products, LLC | 69076-200 |